about
Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer.Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways.Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation.Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells.Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.Functional and physical interaction of the human ARF tumor suppressor with Tat-binding protein-1.Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signaturesATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines.Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins.Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma.Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia.Overexpression of YAP1 induces immortalization of normal human keratinocytes by blocking clonal evolutionCurcumin induces apoptosis in JAK2-mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways.Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthasep63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissueClone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromesTwo conserved glycine residues in mammalian and Dictyostelium Rictor are required for mTORC2 activity and integrityHighly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
P50
Q33251998-097552FF-9F16-4476-B11A-4F60D8A1F092Q33427728-88B17513-E611-464D-8DC8-8F834158F4E1Q34632614-DDEACC21-8E5B-4ACA-9BD9-F738DC5F11D9Q35142318-1CAB2CC9-9F40-4DD4-BC70-A95A4ACC45DFQ35390924-1EF516F6-D3E8-4CC9-9B40-E08BD3989D7CQ35525069-55B49D84-C2F7-4957-AB4C-A6BBBC38F259Q38347016-96ACC567-3350-490F-8DEB-6647602F9356Q38390072-CEE8DDED-DD3B-4839-BBA1-45165CE009FEQ38943647-A74AAF3F-6C2C-436B-9D3D-6E3E8C6551FDQ39535120-DB9AB9C5-6FD5-4BFC-84BB-5C586462B4ECQ39621469-22F3D520-5CF7-47E6-88E4-A996349C63E4Q39653723-304EDC83-9D05-4B47-A057-D3E6F6C423D3Q39782838-1A656629-418C-4B4E-A8FE-D2CF7D655C68Q39888318-EFF7ED2C-1541-440D-98EE-DCC84A556B10Q40100847-422F8D5C-2CFF-4B5C-838B-5791E4C92A18Q41837629-ACA10826-617D-46D8-B577-96A0B6568F70Q42530532-8BC38EA7-F2BF-40FE-9E7A-723C4252770EQ46089043-30B2CE34-C51E-46C8-8A2E-A0523531DF0CQ50178743-6C58A169-66E7-4C57-85D5-0355F72D282DQ62661552-2131AC93-3A68-4310-ACDE-D9D19F2E3BAAQ64938451-EA2C6EFB-D859-430F-9613-E095A53F4CE1Q80218915-7085114B-775D-4E6A-A0A6-005BA6935B34Q83357806-ECF6B426-885C-48EF-9491-6FA6202A3594Q89522724-26CD2F5C-72AE-4617-AD6E-600BB528BC6BQ90949848-42021114-1DC5-4599-A7DC-23CCF3F36024Q92814941-A67D1BEB-5F34-4A34-9040-D5FAB3BA5568
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Lo Iacono
@ast
Marco Lo Iacono
@en
Marco Lo Iacono
@es
Marco Lo Iacono
@nl
type
label
Marco Lo Iacono
@ast
Marco Lo Iacono
@en
Marco Lo Iacono
@es
Marco Lo Iacono
@nl
prefLabel
Marco Lo Iacono
@ast
Marco Lo Iacono
@en
Marco Lo Iacono
@es
Marco Lo Iacono
@nl
P106
P1153
12795511700
P31
P496
0000-0002-3936-4472